Literature DB >> 24960665

Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests.

Narjes Kacem1, Saloua Jemni-Yacoub2, Jacques Chiaroni3, Pascal Bailly3, Monique Silvy3.   

Abstract

BACKGROUND: The choice of a molecular test for first intention determination of paternal RHD zygosity, before entering into invasive diagnostics, is important for the management of pregnancies at risk of haemolytic disease of the foetus and newborn related to anti-RhD.
MATERIALS AND METHODS: RHD zygosity was evaluated in 370 RH:1 Tunisian donors by polymerase chain reaction - sequence-specific polymorphism (PCR-SSP) analysis and polymerase chain reaction - restriction fragment length polymorphism (PCR-RFLP) amplification of hybrid Rhesus box and by real time quantitative polymerase chain reaction (RQ-PCR) specific for RHD exon 5. To evaluate the accuracy of molecular tests in the cases of discordant results, the ten exons of RHD and Rhesus boxes were amplified by PCR and sequenced.
RESULTS: Molecular investigations revealed that our 370 donors comprise 193 dizygous and 145 hemizygous individuals and 32 subjects whose zygosity remains unknown. Positive predictive values were higher than 99% for all the methods, reaching 100% for RQ-PCR. Negative predictive values were 83.24%, 87.27% and 98% for PCR-SSP, PCR-RFLP and RQ-PCR respectively. This study also revealed 19 novel Rhesus box polymorphisms and three novel RHD alleles: RHD(Trp185Stop), RHD(Ala176Thr) and RHD(Ile342Ile). DISCUSSION: RQ-PCR is the most convenient method for first intention determination of paternal RHD zygosity in Tunisians. However, taking into account positive and negative predictive values, PCR-RFLP could be an alternative despite the heterogeneity of Rhesus boxes and the complexity of RHD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24960665      PMCID: PMC4317091          DOI: 10.2450/2014.0308-13

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  22 in total

1.  RHD zygosity assignments based on most probable genotype and hybrid Rhesus box detection in Tunisia.

Authors:  Narjes Kacem; Tahar Chakroun; Hajer Moussa; Saïda Abdelkefi; Betoul Houissa; Jacques Chiaroni; Saloua Jemni Yacoub
Journal:  Transfus Med       Date:  2012-07-04       Impact factor: 2.019

2.  Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.

Authors:  Kevin J Pirelli; Bradley C Pietz; Susan T Johnson; Holly L Pinder; Daniel B Bellissimo
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

3.  Genetic mechanisms of Rhesus box variation.

Authors:  Franz F Wagner; Joann M Moulds; Willy A Flegel
Journal:  Transfusion       Date:  2005-03       Impact factor: 3.157

4.  Molecular analysis of inactive and active RHD alleles in native Congolese cohorts.

Authors:  Mhammed Touinssi; Sylvie Chapel-Fernandes; Thomas Granier; Amelia Bokilo; Pascal Bailly; Jacques Chiaroni
Journal:  Transfusion       Date:  2009-04-01       Impact factor: 3.157

5.  Molecular background of D-negative phenotype in the Tunisian population.

Authors:  H Moussa; M Tsochandaridis; T Chakroun; S Jridi; B Abdelneji; S Hmida; M Silvy; P Bailly; J Gabert; A Levy-Mozziconacci; Saloua Jemni-Yacoub
Journal:  Transfus Med       Date:  2012-03-16       Impact factor: 2.019

Review 6.  Management and prevention of red cell alloimmunization in pregnancy: a systematic review.

Authors:  Kenneth J Moise; Pedro S Argoti
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

7.  Molecular characterization of a new D- - haplotype in a Comorian man.

Authors:  M Silvy; S Chapel-Fernandes; S Beley; C Durousseau; T Granier; J P Zappitelli; P Bailly; J Chiaroni
Journal:  Vox Sang       Date:  2012-06-11       Impact factor: 2.144

8.  The highly variable RH locus in nonwhite persons hampers RHD zygosity determination but yields more insight into RH-related evolutionary events.

Authors:  Martine G H M Grootkerk-Tax; Petra A Maaskant-van Wijk; Judith van Drunen; C Ellen van der Schoot
Journal:  Transfusion       Date:  2005-03       Impact factor: 3.157

Review 9.  Management of rhesus alloimmunization in pregnancy.

Authors:  Kenneth J Moise
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

10.  A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.

Authors:  Ala Szczepura; Leeza Osipenko; Karoline Freeman
Journal:  BMC Pregnancy Childbirth       Date:  2011-01-18       Impact factor: 3.007

View more
  2 in total

1.  A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Authors:  Willy A Flegel; Thierry Peyrard; Jacques Chiaroni; Christophe Tournamille; Déborah Jamet; France Pirenne
Journal:  Blood Transfus       Date:  2018-05-03       Impact factor: 3.443

2.  Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.

Authors:  Mouna Ouchari; Kshitij Srivastava; Houda Romdhane; Saloua Jemni Yacoub; Willy Albert Flegel
Journal:  Transfusion       Date:  2017-11-29       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.